Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.92M Buy
88,154
+7,451
+9% +$237K 0.43% 69
2014
Q4
$2.38M Sell
80,703
-5,942
-7% -$170K 0.37% 80
2014
Q3
$2.44M Buy
86,645
+4,829
+6% +$136K 0.39% 80
2014
Q2
$2.3M Sell
81,816
-10,011
-11% -$285K 0.39% 81
2014
Q1
$2.8M Buy
91,827
+4,976
+6% +$148K 0.55% 49
2013
Q4
$2.52M Buy
86,851
+5,764
+7% +$168K 0.83% 28
2013
Q3
$2.21M Buy
81,087
+6,421
+9% +$175K 0.86% 27
2013
Q2
$1.99M Buy
+74,666
New +$2.06M 0.71% 33

Other funds holding PFE

Sterne Agee Group's PFE Position: Q1 2015 in Review

Sterne Agee Group increased its Pfizer (PFE) stake by 9.2% in Q1 2015, buying an estimated $237K and bringing the position to 88,154 shares worth $2.92M. The position accounts for 0.43% of the portfolio, ranked #69.

Sterne Agee Group first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. 1,874 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Sterne Agee Group held 88,154 shares of Pfizer worth $2.92M as of Q1 2015.
  • Sterne Agee Group bought 7,451 Pfizer shares in Q1 2015, an estimated $237K.
  • Pfizer made up 0.43% of Sterne Agee Group's portfolio in Q1 2015, its #69 holding.
  • Sterne Agee Group first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
  • 1,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.